Dabur Project
Dabur Project
Dabur India Limited is the fourth largest FMCG Company in India with interests
in Health care, Personal care and Food products. Building on a legacy of quality
and experience for over 100 years, today Dabur has a turnover of Rs.1232
Crore with powerful brands like Dabur Amla, Dabur Chyawanprash, Vatika,
Hajmola & Real.
The story of Dabur began with a small, but visionary endeavor by Dr. S. K.
Burman, a physician tucked away in Bengal. His mission was to provide
effective and affordable cure for ordinary people in far-flung villages. With
missionary zeal and fervor, Dr. Burman undertook the task of preparing natural
cures for the killer diseases of those days, like cholera, malaria and plague.
Soon the news of his medicines traveled, and he came to be known as the
trusted 'Daktar' or Doctor who came up with effective cures. And that is how
his venture Dabur got its name - derived from the Devanagri rendition of
Daktar Burman. Dr. Burman set up Dabur in 1884 to produce and dispense
Ayurvedic medicines. Reaching out to a wide mass of people who had no
access to proper treatment. Dr. S. K. Burman's commitment and ceaseless
efforts resulted in the company growing from a fledgling medicine
manufacturer in a small Calcutta house, to a household name that at once
evokes trust and reliability.
1884 - Established by Dr. S K Burman at Kolkata
1896 - First production unit established at Garhia (W.B.)
1919 First R&D unit established
Early 1900s - Production of Ayurvedic medicines
Dabur identifies nature-based Ayurvedic medicines as its area of specialisation.
It is the first Company to provide health care through scientifically tested and
automated production of formulations based on our traditional science.
1930- Automation and up gradation of Ayurvedic products manufacturing
initiated
1936 - Dabur (Dr. S K Burman) Pvt.Ltd. Incorporated
1940- Personal care through Ayurveda
Dabur introduces Indian consumers to personal care through Ayurveda, with
the launch of Dabur Amla Hair Oil. So popular is the product that it becomes
the largest selling hair oil brand in India.
1949 - Launched Dabur Chyawanprash in tin pack
Widening the popularity and usage of traditional Ayurvedic products
continues. The ancient restorative Chyawanprash is launched in packaged
form, and becomes the first branded
1957 - Computerization of operations initiated
1970 Entered Oral Care & Digestive segment
Addressing rural markets where homemade oral care is more popular than
multinational brands, Dabur introduces Lal Dant Manjan. With this a
conveniently packaged herbal toothpowder is made available at affordable
costs to the masses.
1972 Shifts base to Delhi from Calcutta
1978 - Launches Hajmola tablet
Dabur continues to make innovative products based on traditional
formulations that can
provide holistic care in our daily life. An Ayurvedic medicine used as a digestive
aid is branded
and launched as the popular Hajmola tablet.
1979 - Dabur Research Foundation set up
1979 - Commercial production starts at Sahibabad (U.P.), the most modern
herbal medic
plant at that time
1984 Dabur completes 100 years
1988 - Launches pharmaceutical medicines
1989 Care with fun
The Ayurvedic digestive formulation is converted into children's fun product
with the launch of Hajmola Candy. In an innovative move, a curative product is
converted to a confectionery item for wider usage.
1994 - Comes out with first public issue
1996 Enters oncology segment
2000 - Leadership in health care
Dabur establishes its leadership in health care as one of only two companies
worldwide to launch the anti-cancer drug Intaxel (Paclitaxel). Dabur Research
Foundation develops an Eco- friendly process to extract the drug from its plant
source
2003 Enters foods business with the launch of Real Fruit Juice
2005 - Burman family hands over management of the company to
professionals
2008 - The 1,000-crore mark
Dabur establishes its market leadership status by staging a turnover of Rs.1000
corers. Across a span of over 100 years, Dabur has grown from a small
beginning based on traditional health care. To a commanding position amongst
an august league of large corporate businesses.
2009 Super specialty drugs
with the setting up of Dabur Oncology's sterile cytotoxic facility, the Company
gains entry into the highly specialised area of cancer therapy. The state-of-the-
art plant and laboratory in the UK have approval from the MCA of UK. They
follow FDA guidelines for production of drugs specifically for European and
American markets.
2010 - Dabur record sales of Rs 1163.19 crore on a net profit of Rs 64.4
crore
2011 - Dabur demerges Pharmaceuticals business
CORE VALUES
Ownership: This is our company. We accept personal responsibility, and
accountability to meet business needs
Passion For Winning: We all are leaders in our area of responsibility, with a
deep commitment to deliver results. We are determined to be the best at
doing what matters most
People Development: People are our most important asset. We add value
through result driven training, and we encourage & reward excellence
Consumer Focus: We have superior understanding of consumer needs and
develop products to fulfill them better
Team Work: We work together on the principle of mutual trust & transparency
in a boundary-less organization. We are intellectually honest in advocating
proposals, including recognizing risks
Innovation: Continuous innovation in products & processes is the basis of our
success
Integrity: We are committed to the achievement of business success with
integrity. We are honest with consumers, with business partners and with each
other
DABUR AT A GLANCE
Dabur India Limited has marked its presence with some very significant
achievements and today commands a market leadership status. Our story of
success is based on dedication to nature, corporate and process hygiene,
dynamic leadership and commitment to our partners and stakeholders.
The results of our policies and initiatives speak for themselves.
Leading consumer goods company in India with 4th largest turnover of
Rs.1163.2 Crore (FY02)
3 major strategic business units (SBU) - Family Products Division (FPD), Health
Care Products Division (HCPD) and Dabur Ayurvedic Specialties (DASL)
5 Subsidiary Group companies - Dabur Foods, Dabur Nepal, Dabur Oncology,
Dabur Pharma and Dabur Egypt
13 ultra-modern manufacturing units spread across 4 countries
Products marketed in over 50 countries
Wide and deep market penetration with 47 C&F agents, more than 5000
distributors and over 1.5 million retail outlets all over India
FPD, dealing with personal care, the largest SBU contributing to 45% sales of
Dabur
• Products related to Hair Care, Skin Care, Oral Care and Foods
⚫ 3 leading brands - Vatika, Amla Hair Oil and Lal Dant Manjan with Rs.100
crore turnover each
• Vatika Hair Oil & Shampoo the high growth brand
Strategic positioning of Honey as food product, leading to market leadership
(over 40%) in branded honey market
HCPD, dealing with daily health care, 2nd largest SBU with 28% share in sales
Products related to Health Supplements, Digestives, Baby Care and Natural
Cures
• Leadership in Ayurvedic and herbal products market with highly popular
brands
Dabur Chyawanprash the largest selling Ayurvedic medicine with 65% (Rs.127
crore) market share.
⚫ Charted high growth with 15% in 2001.
Dabur Chyawanprash and Hajmola account for sales of over Rs.100 crore each
Leader in herbal digestives with 90% market share
• Hajmola tablets in command with 75% market share of digestive tablets
category
• Dabur Lal Tail tops baby massage oil market with 35% of total share
DASL, dealing with classical Ayurvedic medicines
Has more than 250 products sold through prescriptions as well as over the
counter
• Major categories in traditional formulations include
-Asav Arishtas
-Ras Rasayanas
-Churnas
- Medicated Oils
A special herbal health care and personal care range successfully selling in
markets of the Middle East, Far East and several European countries.
Inroads into European and American markets that have good potential due to
resurgence of the back-to-nature movement.
Export of Active Pharmaceutical Ingredients (APIs), manufactured under strict
international quality benchmarks, to Europe, Latin America, Africa, and other
Asian countries.
Export of food and textile grade natural gums, extracted from traditional plant
sources.
Partnerships and Production
Strategic partnerships with leading multinational food and health care
companie to introduce innovations in products and services.
Equal opportunities
All staff are entitled to and can expect to receive training they need to carry
out their current role. This includes fixed-term contract or short-term contract
staff.
Permanent employees can expect to benefit from further commitment for
each individual to devote at least 5 days a year towards training and
development. First priority will be towards job-related training, but we will also
encourage individuals to undertake personal development training. This may
entail taking professional qualifications; undertaking research into a particular
field of interest or experiencing a particular aspect of another job in order to
gain an insight into the role and fuller understanding of the work.
Training should not be viewed purely as "attending a training course". There
are a variety of different methods that can be used to help train and develop
individuals and Services will be happy to help individuals and managers select
the most appropriate method. For-example, using open learning materials;
computer-based packages; videos or CD-ROMs; e-learning; and reading
literature, to name but a few.
Shared responsibilities
It is recognizing the need for everyone to learn and develop their skills on a
continuous basis and will support individuals to help them achieve this.
Equally, the company expects individuals to take on some responsibility for
their own self-development. For example, identifying suitable training activities
(with the help of line managers and Personnel Services) and adopting a flexible
and positive approach to any training and development that is identified with
them.
Identifying training & development needs
Identifying training and development needs, and helping individuals to
improve their performance, are key responsibilities for line managers, so they
are expected to be actively involved in their team's training and development.
Line managers are also responsible of measuring the effectiveness of any
training and development undertaken by team members, with assistance from
Personnel Services.
The skills and knowledge that will be needed for the future success of the
company will become apparent as each year's business (corporate) plan is
drafted and communicated to teams within the company and individual
performance objectives agreed. Where individual skills, knowledge or the
development of competencies are needed to achieve our business objectives,
these should be recorded on the Development Needs Assessment plan, which
forms part of our Performance Review process.
Setting and evaluating learning objectives/outcomes
The company has a number of key business objectives that it needs to achieve.
These objectives can be achieved only through harnessing the abilities and
skills of everyone in the company and by releasing potential and maximizing
opportunities for development. If individuals need to learn in order to achieve
business objectives, it is important that any training and development in which
we invest has a relationship to our business objectives, so we can demonstrate
the contribution learning makes towards overall organizational success.
Company sponsorship
Company recognises the need for continuous professional development and
are pleased to be able to offer a sponsorship scheme to all permanent and
fixed-term employees (whose contracts are for at least one year). The scheme
covers professional, academic or NVQ (or equivalent) qualifications. The
following guidelines are designed to give individuals an idea of the sort of
funding that may be available and how individuals may apply.